» Articles » PMID: 29127556

Nationwide Multicenter Kidney Biopsy Study of Japanese Patients with Hypertensive Nephrosclerosis

Abstract

Background: Nephrosclerosis is an increasingly reason for dialysis in Japan. However, kidney biopsy specimens for hypertensive nephrosclerosis are very limited; thus, the pathologic evaluation of hypertensive nephrosclerosis currently remains unclear.

Methods: Clinical and pathologic data of a total of 184 biopsy-confirmed hypertensive nephrosclerosis patients were collected from 13 centers throughout Japan. Seven pathological findings were assessed in this study. The outcomes of interest for this study were dialysis, composite kidney events, cardiovascular events, and all-cause mortality.

Results: The Green and Yellow (G&Y), Orange, and Red groups of the chronic kidney diseases (CKD) heat map contained 36, 57, and 91 cases, respectively. The mean observation period was 7.3 ± 5.2 (median, IQR; 6.1, 2.6-9.7) years. Global glomerulosclerosis (GScle), interstitial fibrosis and tubular atrophy (IFTA), arteriolar hyalinosis in Red exhibited higher scores than those in G&Y and Orange. The incidence rates of the composite kidney end points in 100 person-years for the G&Y, Orange, and Red groups were 1.42, 2.16, and 3.98, respectively. In the univariate Cox analysis for the composite kidney end points, GScle, IFTA and interstitial cell infiltration exhibited statistically significant high hazard ratios (1.18, 1.84, 1.69, respectively). However, after adjustment for clinical and medication data, the Red group in the CKD heat map category was risk factor for the composite kidney end points (HR 9.51).

Conclusions: In summary, although pathologic findings had minor impacts on the prediction of composite outcomes in this study, the clinical stage of the CKD heat map is a good predictor of composite kidney events.

Citing Articles

Deep learning-based histopathological assessment of tubulo-interstitial injury in chronic kidney diseases.

Suzuki N, Kojima K, Malvica S, Yamasaki K, Chikamatsu Y, Oe Y Commun Med (Lond). 2025; 5(1):3.

PMID: 39757253 PMC: 11701080. DOI: 10.1038/s43856-024-00708-3.


Clinicopathological discordance in biopsy-proven nephrosclerosis: a nationwide cross-sectional study of the Japan Renal Biopsy Registry (J-RBR).

Sumida K, Takeda A, Furuichi K, Uesugi N, Ubara Y, Sato H Clin Exp Nephrol. 2021; 26(4):325-332.

PMID: 34812966 PMC: 8930907. DOI: 10.1007/s10157-021-02161-1.


Nonproteinuric diabetic kidney disease.

Yamanouchi M, Furuichi K, Hoshino J, Ubara Y, Wada T Clin Exp Nephrol. 2020; 24(7):573-581.

PMID: 32236782 PMC: 7271053. DOI: 10.1007/s10157-020-01881-0.


Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort study in Aichi, Japan.

Inaguma D, Ito E, Takahashi K, Hayashi H, Koide S, Hasegawa M Clin Exp Nephrol. 2018; 22(6):1360-1370.

PMID: 29882111 DOI: 10.1007/s10157-018-1592-0.


Clinico-pathological features of kidney disease in diabetic cases.

Furuichi K, Shimizu M, Okada H, Narita I, Wada T Clin Exp Nephrol. 2018; 22(5):1046-1051.

PMID: 29564666 PMC: 6154170. DOI: 10.1007/s10157-018-1556-4.

References
1.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53(6):982-92. DOI: 10.1053/j.ajkd.2008.12.034. View

2.
Fogo A, Breyer J, Smith M, Cleveland W, Agodoa L, Kirk K . Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int. 1997; 51(1):244-52. DOI: 10.1038/ki.1997.29. View

3.
Appel L, Wright Jr J, Greene T, Kusek J, Lewis J, Wang X . Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med. 2008; 168(8):832-9. PMC: 3870204. DOI: 10.1001/archinte.168.8.832. View

4.
Appel L, Wright Jr J, Greene T, Agodoa L, Astor B, Bakris G . Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010; 363(10):918-29. PMC: 3662974. DOI: 10.1056/NEJMoa0910975. View

5.
Suzuki H, Kobayashi K, Ishida Y, Kikuta T, Inoue T, Hamada U . Patients with biopsy-proven nephrosclerosis and moderately impaired renal function have a higher risk for cardiovascular disease: 15 years' experience in a single, kidney disease center. Ther Adv Cardiovasc Dis. 2015; 9(3):77-86. DOI: 10.1177/1753944715578596. View